v3 Template
P

Pinnacle Medicines

Biotechnology / Pharmaceuticals
Founded
--
Employees
--
Total Funding
$89.0M
Funding Rounds
1
Last Funding
2026-03-26

About Pinnacle Medicines

Pinnacle Medicines focuses on transforming patients' lives by developing oral peptide therapeutics. They apply the power of peptides to create oral therapies that combine biological precision with everyday convenience, aiming to improve the quality of life for patients with chronic diseases.

Products & Services

Oral Peptide Therapeutics:Developing a first-in-class oral peptide pipeline targeting validated biologic areas with significant unmet needs, using state-of-the-art oral formulation to achieve antibody-like efficacy with a pill.

Specialties

Oral Peptide Therapeutics AI and Physics in Drug Discovery De Novo Design Lead Optimization

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B 		A: 89000000
MR: -
FA: $89 million
FAN: 89000000 		D: 2026-03-26
FD: 2026-03-26 		7 investors
Series B Latest
2026-03-26
$89.0M
7 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Pinnacle Medicines Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Pharmaceuticals

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro